港股異動丨蘋果概念股走低:高偉電子跌超6%,舜宇光學跌5.8%
因中美超預期互降關稅,昨日大幅上漲的蘋果概念股今日未能延續上漲行情,其中,高偉電子跌超6%,舜宇光學跌5.8%,比亞迪電子跌超5%,丘鈦科技跌超4%。消息上,“6.18”購物節前夕,蘋果手機再度降價引發市場關注。業內人士表示,蘋果手機此次大幅降價,雖然在短期內可能會刺激部分消費者的購買慾望,但從長期來看,要從根本上扭轉其在中國市場的銷量下滑趨勢,還需要在產品創新、本地化策略以及價格策略上做出更全面的調整。此外據悉,有知情人士表示,蘋果正在權衡是否上調今年秋季推出的新款iPhone售價。該公司正探索將漲價與新功能和新設計“捆綁”的策略,同時努力避免外界將價格上漲與美國加徵關稅聯繫起來。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.